REFERENCES
Angelin-Duclos, C., Cattoretti, G., Lin, K. I., & Calame, K. (2000).
Commitment of B lymphocytes to a plasma cell fate is associated with
Blimp-1 expression in vivo. J Immunol, 165 (10), 5462-5471.
doi:10.4049/jimmunol.165.10.5462
Arce, E., Jackson, D. G., Gill, M. A., Bennett, L. B., Banchereau, J.,
& Pascual, V. (2001). Increased frequency of pre-germinal center B
cells and plasma cell precursors in the blood of children with systemic
lupus erythematosus. J Immunol, 167 (4), 2361-2369.
doi:10.4049/jimmunol.167.4.2361
Ba, M., Long, H., Yan, Z., Wang, S., Wu, Y., Tu, Y., … Cui, S.
(2018). BRD4 promotes gastric cancer progression through the
transcriptional and epigenetic regulation of c-MYC. J Cell
Biochem, 119 (1), 973-982. doi:10.1002/jcb.26264
Bandukwala, H. S., Gagnon, J., Togher, S., Greenbaum, J. A., Lamperti,
E. D., Parr, N. J., … Rao, A. (2012). Selective inhibition of
CD4+ T-cell cytokine production and autoimmunity by BET protein and
c-Myc inhibitors. Proc Natl Acad Sci U S A, 109 (36), 14532-14537.
doi:10.1073/pnas.1212264109
Belkina, A. C., Blanton, W. P., Nikolajczyk, B. S., & Denis, G. V.
(2014). The double bromodomain protein Brd2 promotes B cell expansion
and mitogenesis. J Leukoc Biol, 95 (3), 451-460.
doi:10.1189/jlb.1112588
Cappione, A., 3rd, Anolik, J. H., Pugh-Bernard, A., Barnard, J.,
Dutcher, P., Silverman, G., & Sanz, I. (2005). Germinal center
exclusion of autoreactive B cells is defective in human systemic lupus
erythematosus. J Clin Invest, 115 (11), 3205-3216.
doi:10.1172/jci24179
Carsetti, R., Rosado, M. M., & Wardmann, H. (2004). Peripheral
development of B cells in mouse and man. Immunol Rev, 197 ,
179-191. doi:10.1111/j.0105-2896.2004.0109.x
Cheung, K. L., Zhang, F., Jaganathan, A., Sharma, R., Zhang, Q., Konuma,
T., … Zhou, M. M. (2017). Distinct Roles of Brd2 and Brd4 in
Potentiating the Transcriptional Program for Th17 Cell Differentiation.Mol Cell, 65 (6), 1068-1080.e1065.
doi:10.1016/j.molcel.2016.12.022
Devaiah, B. N., Lewis, B. A., Cherman, N., Hewitt, M. C., Albrecht, B.
K., Robey, P. G., … Singer, D. S. (2012). BRD4 is an atypical
kinase that phosphorylates serine2 of the RNA polymerase II
carboxy-terminal domain. Proc Natl Acad Sci U S A, 109 (18),
6927-6932. doi:10.1073/pnas.1120422109
Donato, E., Croci, O., Sabò, A., Muller, H., Morelli, M. J., Pelizzola,
M., & Campaner, S. (2017). Compensatory RNA polymerase 2 loading
determines the efficacy and transcriptional selectivity of JQ1 in
Myc-driven tumors. Leukemia, 31 (2), 479-490.
doi:10.1038/leu.2016.182
Filippakopoulos, P., Picaud, S., Mangos, M., Keates, T., Lambert, J. P.,
Barsyte-Lovejoy, D., … Knapp, S. (2012). Histone recognition and
large-scale structural analysis of the human bromodomain family.Cell, 149 (1), 214-231. doi:10.1016/j.cell.2012.02.013
Grimaldi, C. M., Cleary, J., Dagtas, A. S., Moussai, D., & Diamond, B.
(2002). Estrogen alters thresholds for B cell apoptosis and activation.J Clin Invest, 109 (12), 1625-1633. doi:10.1172/jci14873
Grimaldi, C. M., Michael, D. J., & Diamond, B. (2001). Cutting edge:
expansion and activation of a population of autoreactive marginal zone B
cells in a model of estrogen-induced lupus. J Immunol, 167 (4),
1886-1890. doi:10.4049/jimmunol.167.4.1886
Hiepe, F., Dörner, T., Hauser, A. E., Hoyer, B. F., Mei, H., &
Radbruch, A. (2011). Long-lived autoreactive plasma cells drive
persistent autoimmune inflammation. Nat Rev Rheumatol, 7 (3),
170-178. doi:10.1038/nrrheum.2011.1
Hochberg, M. C. (1997). Updating the American College of Rheumatology
revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum, 40 (9), 1725. doi:10.1002/art.1780400928
Kallies, A., Hasbold, J., Tarlinton, D. M., Dietrich, W., Corcoran, L.
M., Hodgkin, P. D., & Nutt, S. L. (2004). Plasma cell ontogeny defined
by quantitative changes in blimp-1 expression. J Exp Med, 200 (8),
967-977. doi:10.1084/jem.20040973
Kong, I. Y., Rimes, J. S., Light, A., Todorovski, I., Jones, S., Morand,
E., … Hawkins, E. D. (2020). Temporal Analysis of Brd4
Displacement in the Control of B Cell Survival, Proliferation, and
Differentiation. Cell Rep, 33 (3), 108290.
doi:10.1016/j.celrep.2020.108290
Leandro, M. J., Edwards, J. C., Cambridge, G., Ehrenstein, M. R., &
Isenberg, D. A. (2002). An open study of B lymphocyte depletion in
systemic lupus erythematosus. Arthritis Rheum, 46 (10), 2673-2677.
doi:10.1002/art.10541
Looney, R. J., Anolik, J. H., Campbell, D., Felgar, R. E., Young, F.,
Arend, L. J., … Sanz, I. (2004). B cell depletion as a novel
treatment for systemic lupus erythematosus: a phase I/II dose-escalation
trial of rituximab. Arthritis Rheum, 50 (8), 2580-2589.
doi:10.1002/art.20430
Mele, D. A., Salmeron, A., Ghosh, S., Huang, H. R., Bryant, B. M., &
Lora, J. M. (2013). BET bromodomain inhibition suppresses TH17-mediated
pathology. J Exp Med, 210 (11), 2181-2190.
doi:10.1084/jem.20130376
Nutt, S. L., Hodgkin, P. D., Tarlinton, D. M., & Corcoran, L. M.
(2015). The generation of antibody-secreting plasma cells. Nat Rev
Immunol, 15 (3), 160-171. doi:10.1038/nri3795
Nutt, S. L., Taubenheim, N., Hasbold, J., Corcoran, L. M., & Hodgkin,
P. D. (2011). The genetic network controlling plasma cell
differentiation. Semin Immunol, 23 (5), 341-349.
doi:10.1016/j.smim.2011.08.010
Odendahl, M., Jacobi, A., Hansen, A., Feist, E., Hiepe, F., Burmester,
G. R., … Dörner, T. (2000). Disturbed peripheral B lymphocyte
homeostasis in systemic lupus erythematosus. J Immunol, 165 (10),
5970-5979. doi:10.4049/jimmunol.165.10.5970
Parodis, I., Stockfelt, M., & Sjöwall, C. (2020). B Cell Therapy in
Systemic Lupus Erythematosus: From Rationale to Clinical Practice.Front Med (Lausanne), 7 , 316. doi:10.3389/fmed.2020.00316
Radbruch, A., Muehlinghaus, G., Luger, E. O., Inamine, A., Smith, K. G.,
Dörner, T., & Hiepe, F. (2006). Competence and competition: the
challenge of becoming a long-lived plasma cell. Nat Rev Immunol,
6 (10), 741-750. doi:10.1038/nri1886
Reddy, V., Cambridge, G., Isenberg, D. A., Glennie, M. J., Cragg, M. S.,
& Leandro, M. (2015). Internalization of rituximab and the efficiency
of B Cell depletion in rheumatoid arthritis and systemic lupus
erythematosus. Arthritis Rheumatol, 67 (8), 2046-2055.
doi:10.1002/art.39167
Santulli-Marotto, S., Qian, Y., Ferguson, S., & Clarke, S. H. (2001).
Anti-Sm B cell differentiation in Ig transgenic MRL/Mp-lpr/lpr mice:
altered differentiation and an accelerated response. J Immunol,
166 (8), 5292-5299. doi:10.4049/jimmunol.166.8.5292
Shapiro-Shelef, M., Lin, K. I., McHeyzer-Williams, L. J., Liao, J.,
McHeyzer-Williams, M. G., & Calame, K. (2003). Blimp-1 is required for
the formation of immunoglobulin secreting plasma cells and pre-plasma
memory B cells. Immunity, 19 (4), 607-620.
doi:10.1016/s1074-7613(03)00267-x
Shim, J. M., Lee, J. S., Russell, K. E., Wiegman, C. H., Barnes, P. J.,
Fear, D., … Durham, A. L. (2017). BET proteins are a key
component of immunoglobulin gene expression. Epigenomics, 9 (4),
393-406. doi:10.2217/epi-2016-0147
Shlomchik, M. J., & Weisel, F. (2012). Germinal center selection and
the development of memory B and plasma cells. Immunol Rev,
247 (1), 52-63. doi:10.1111/j.1600-065X.2012.01124.x
Sun, Y., Wang, Y., Toubai, T., Oravecz-Wilson, K., Liu, C., Mathewson,
N., … Reddy, P. (2015). BET bromodomain inhibition suppresses
graft-versus-host disease after allogeneic bone marrow transplantation
in mice. Blood, 125 (17), 2724-2728.
doi:10.1182/blood-2014-08-598037
Toniolo, P. A., Liu, S., Yeh, J. E., Moraes-Vieira, P. M., Walker, S.
R., Vafaizadeh, V., … Frank, D. A. (2015). Inhibiting STAT5 by
the BET bromodomain inhibitor JQ1 disrupts human dendritic cell
maturation. J Immunol, 194 (7), 3180-3190.
doi:10.4049/jimmunol.1401635
Wei, C., Anolik, J., Cappione, A., Zheng, B., Pugh-Bernard, A., Brooks,
J., … Sanz, I. (2007). A new population of cells lacking
expression of CD27 represents a notable component of the B cell memory
compartment in systemic lupus erythematosus. J Immunol, 178 (10),
6624-6633. doi:10.4049/jimmunol.178.10.6624
Wei, S., Sun, Y., & Sha, H. (2015). Therapeutic targeting of BET
protein BRD4 delays murine lupus. Int Immunopharmacol, 29 (2),
314-319. doi:10.1016/j.intimp.2015.10.036
Yang, H., Wang, H., & Jaenisch, R. (2014). Generating genetically
modified mice using CRISPR/Cas-mediated genome engineering. Nat
Protoc, 9 (8), 1956-1968. doi:10.1038/nprot.2014.134
Yang, Z., Yik, J. H., Chen, R., He, N., Jang, M. K., Ozato, K., & Zhou,
Q. (2005). Recruitment of P-TEFb for stimulation of transcriptional
elongation by the bromodomain protein Brd4. Mol Cell, 19 (4),
535-545. doi:10.1016/j.molcel.2005.06.029
Yurasov, S., Tiller, T., Tsuiji, M., Velinzon, K., Pascual, V.,
Wardemann, H., & Nussenzweig, M. C. (2006). Persistent expression of
autoantibodies in SLE patients in remission. J Exp Med, 203 (10),
2255-2261. doi:10.1084/jem.20061446
Yurasov, S., Wardemann, H., Hammersen, J., Tsuiji, M., Meffre, E.,
Pascual, V., & Nussenzweig, M. C. (2005). Defective B cell tolerance
checkpoints in systemic lupus erythematosus. J Exp Med, 201 (5),
703-711. doi:10.1084/jem.20042251
Zhang, W., Prakash, C., Sum, C., Gong, Y., Li, Y., Kwok, J. J., …
Chin, K. C. (2012). Bromodomain-containing protein 4 (BRD4) regulates
RNA polymerase II serine 2 phosphorylation in human CD4+ T cells.J Biol Chem, 287 (51), 43137-43155. doi:10.1074/jbc.M112.413047